Trusted News Discovery Since 2008
{{/content}}
Johnson & Johnson COVID-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says
Video Credit: WXYZ Detroit
Published on January 29, 2021 - Duration: 03:49s
Johnson & Johnson COVID-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says
Johnson & Johnson’s one-shot vaccine candidate was found to be 85% effective against the most serious symptoms of COVID-19.
You are here
Related videos from verified sources
Johnson & Jonson vaccine 66% effective 00:26
Video credit: FOX 4 Now Florida - Published on January 30, 2021
Healthcare workers stranded in snow give out vaccine doses set to expire 03:23
Video credit: Bleacher Report AOL - Published on January 30, 2021
Johnson & Johnson's COVID-19 Vaccine Still Has Advantages Despite Less Effectiveness 02:10
Video credit: CBS 11 Dallas - Published on January 30, 2021